Single mutation of the hepatitis E virus stands in the way of sofosbuvir drug’s effectiveness

As No­vo Nordisk hauls in huge sales from its pop­u­lar GLP-1 prod­ucts, the com­pa­ny is think­ing about a fu­ture be­yond obe­si­ty and di­a­betes. Dur­ing a

Share this article When it comes to medicines access, numerous factors may delay or prevent medical products from reaching patients. It is the role of